We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
54 hedge funds and large institutions have $45.9M invested in CASI Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
38% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 16
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.04% less ownership
Funds ownership: 1.24% → 1.2% (-0.04%)
9% less capital invested
Capital invested by funds: $50.2M → $45.9M (-$4.3M)
14% less funds holding
Funds holding: 63 → 54 (-9)
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Holders
54
Holders Change
-9
Holders Change %
-14.29%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
22
Reduced
16
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WSCM
Wellington Shields Capital Management
New York
|
+$1.09M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.07M |
| 3 |
WSC
Wellington Shields & Co
New York
|
+$699K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$287K |
| 5 |
AA
ALPS Advisors
Denver,
Colorado
|
+$254K |
